Streetbeat News

Stock Prices

CMBM

Cambium Networks reported preliminary Q4 2023 revenue of $40M, which falls short of the estimated $47.22M. This indicates a potential revenue miss for the quarter.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 9:05 pm

PPG

PPG Industries, Inc. (NYSE:PPG) reported Q4 earnings of $1.53 per share, surpassing the consensus estimate of $1.50, marking a 25.41% increase from the previous year. Quarterly sales reached $4.35 billion, exceeding estimates of $4.27 billion and showing a 3.94% increase year-over-year.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 9:05 pm

BANR

Banner Corporation (NASDAQ:BANR) reported Q4 earnings with an EPS of $1.34, beating estimates by 3.08% but with a revenue decrease of $19.68 million from the previous year. In the last quarter, a beat on EPS resulted in a 1.6% share price increase the following day.

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:05 pm

BANR

Banner Corporation (NASDAQ:BANR) reported Q4 adjusted earnings of $1.34 per share, surpassing the consensus estimate of $1.30 by 3.08%. However, this represents a 20.24% decrease from the $1.68 per share earned in the same quarter last year. Quarterly sales were $152.46M, exceeding estimates by 8.55% but showing an 11.43% decline from the previous year's $172.14M.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 9:02 pm

M

Macy's has announced plans to close five of its stores and will cut approximately 2,350 jobs starting January 26, according to the Wall Street Journal. This move is part of Macy's ongoing efforts to streamline its operations and adjust to the changing retail landscape.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 9:01 pm

ESPR

Esperion Therapeutics has announced the commencement of a public offering of shares of its common stock. The terms of the offering have not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 9:01 pm

IKNA

Trading for IKNA was halted at 4:00:10 p.m. ET due to pending news. The halt is in place to manage market orderliness and ensure fair information dissemination pending a significant announcement.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 9:00 pm

PYPL

PayPal Holdings, Inc. (NASDAQ:PYPL) shares have experienced volatility, with a recent rise in November, a drop at the end of December and into January, and a rebound attempt that was hindered by a downgrade from Mizuho analyst Dan Dolev. Dolev downgraded PayPal from Buy to Neutral and lowered the price target from $72 to $65, causing a sell-off. Despite this, PayPal shares attempted another comeback on Wednesday and extended gains on Thursday, rising over 4%.

Portfolio Pulse from Ryan Gustafson

January 18, 2024 | 8:58 pm

HBI

HanesBrands Inc. is nearing the end of the sale process for its Champion brand, with bids due by February 21. Goldman Sachs & Co. and Evercore are managing the sale. Potential buyers include Authentic Brands Group, Marquee Brands, WHP Global, and G-III Apparel Group. Despite a 19% decline in Champion's sales last quarter, interest remains due to the brand's strong consumer resonance. HanesBrands faced pressure from Barington Capital Group and is looking to turn around Champion's performance.

Portfolio Pulse from Benzinga Newsdesk

January 18, 2024 | 8:56 pm

ANSS

CVS

GILD

QQQ

REGN

SNPS

SPY

Marc Chaikin, CEO of Chaikin Analytics, believes the 'buy everything' market sentiment is over due to the Federal Reserve's stance on interest rates. He predicts a stock picker's market for 2024, with a bullish outlook on stocks, particularly in the tech and biotech sectors. Synopsys (SNPS) is highlighted for its merger with Ansys (ANSS) and its potential value despite recent share price declines. Chaikin also sees opportunities in biotech companies like Gilead Sciences (GILD) and Regeneron Pharmaceuticals (REGN), as well as CVS Health Corp (CVS).

Portfolio Pulse from Neil Dennis

January 18, 2024 | 8:54 pm